-transparent.png){kind=logo}
We investigated the stoichiometry of the interferon gamma and interferon gamma receptor interaction, using recombinant interferon gamma and recombinant soluble interferon gamma receptor, applying chemical cross-linking and chromatographic techniques, and analyzing the resulting products in denaturing polyacrylamide gels. Interferon gamma cross-linked to itself produced a major band of an apparent molecular mass of 34 kDa, which suggests that it exists as a dimer in physiological buffer and which agrees with published data. Soluble interferon gamma receptor cross-linked to itself produced mainly a 28-kDa band, suggesting that the interferon gamma receptor exists as a monomer. Interferon gamma cross-linked to the soluble interferon gamma receptor resulted in the formation of two main products of apparent molecular masses of 60 and 44 kDa. The predominant 60-kDa band resulted from the cross-linking of one interferon gamma dimer (34 kDa) to one interferon gamma receptor molecule (27 kDa). The 44-kDa band was formed by the cross-linking of one interferon gamma molecule to one interferon gamma receptor. Kinetic studies showed that the cross-linking of interferon gamma dimer to the soluble receptor proceeds through the intermediate formed by cross-linking one molecule of the interferon gamma dimer to the receptor. Reducing and dissociating agents inhibited complex formation. When chromatographed on Sephadex G-100, interferon gamma was eluted as a protein of 34-kDa molecular mass, the soluble interferon gamma receptor as a protein of 40 kDa, and their mixture was eluted in one peak corresponding to an apparent molecular mass of 73 kDa. Sodium dodecyl sulfate-polyacrylamide gel analysis of the eluted mixture showed the presence of both interferon gamma and interferon gamma receptor at a ratio of 2:1. The found results suggest that the interferon gamma receptor binds interferon gamma as a dimer.
M Fountoulakis, and
J F Juranville, and
A Maris, and
L Ozmen, and
G Garotta
September 1998,
Virology,
M Fountoulakis, and
J F Juranville, and
A Maris, and
L Ozmen, and
G Garotta
May 1986,
Journal of immunology (Baltimore, Md. : 1950),
M Fountoulakis, and
J F Juranville, and
A Maris, and
L Ozmen, and
G Garotta
January 1988,
Lymphokine research,
M Fountoulakis, and
J F Juranville, and
A Maris, and
L Ozmen, and
G Garotta
May 2002,
Clinical immunology (Orlando, Fla.),
M Fountoulakis, and
J F Juranville, and
A Maris, and
L Ozmen, and
G Garotta
August 1993,
Immunology,
M Fountoulakis, and
J F Juranville, and
A Maris, and
L Ozmen, and
G Garotta
June 1998,
Journal of molecular endocrinology,
M Fountoulakis, and
J F Juranville, and
A Maris, and
L Ozmen, and
G Garotta
January 2017,
Medecine sciences : M/S,
M Fountoulakis, and
J F Juranville, and
A Maris, and
L Ozmen, and
G Garotta
August 1994,
Journal of reproductive immunology,
M Fountoulakis, and
J F Juranville, and
A Maris, and
L Ozmen, and
G Garotta
October 1994,
Pathology, research and practice,
M Fountoulakis, and
J F Juranville, and
A Maris, and
L Ozmen, and
G Garotta
June 1987,
Immunological reviews,
